Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Clinical trial NCT07172971 · RECRUITING

Trial details

NCT number: NCT07172971
Sponsor: Vanderbilt University Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy (DMD)

Start date: 2026-07-01
Primary completion: 2027-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.